L Julien

Publications (3)

COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns.

Emerging microbes & infections

Avec: Mazet Roseline , Choisnard Luc , Leenhardt Julien , Epaulard Olivier , Brudieu Etienne , Bedouch Pierrick

Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy.

Molecular therapy. Nucleic acids

Avec: Delphine Trochet , Bernard Prudhon , Lylia Mekzine , Mégane Lemaitre , Maud Beuvin , Laura Julien , Sofia Benkhelifa-Ziyyat , Mai Thao Bui , Norma Romero , Marc Bitoun

Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential.

Clinical and experimental medicine

Avec: Sterkens Ann , Janssens Ibo , Meena Megha , De Reu Hans , Van Bruggen Laura , Lambert Julien , Bervoets An , Cools Nathalie

Réseau de co-auteurs

Mazet Roseline 1 collaboration

Choisnard Luc 1 collaboration

Leenhardt Julien 1 collaboration

Epaulard Olivier 1 collaboration

Brudieu Etienne 1 collaboration

Bedouch Pierrick 1 collaboration

Delphine Trochet 1 collaboration

Bernard Prudhon 1 collaboration

Lylia Mekzine 1 collaboration

Mégane Lemaitre 1 collaboration

Maud Beuvin 1 collaboration

Laura Julien 1 collaboration

Sofia Benkhelifa-Ziyyat 1 collaboration

Mai Thao Bui 1 collaboration

Norma Romero 1 collaboration

Marc Bitoun 1 collaboration

Sterkens Ann 1 collaboration

Janssens Ibo 1 collaboration

Meena Megha 1 collaboration

De Reu Hans 1 collaboration

Van Bruggen Laura 1 collaboration

Lambert Julien 1 collaboration

Bervoets An 1 collaboration

Cools Nathalie 1 collaboration